A comprehensive nomenclature for serine proteases with homology to tissue kallikreins by Lundwall, A. et al.
Biol. Chem., Vol. 387, pp. 637–641, June 2006 • Copyright  by Walter de Gruyter • Berlin • New York. DOI 10.1515/BC.2006.082
2006/115
Article in press - uncorrected proof
Nomenclature Paper
A comprehensive nomenclature for serine proteases with
homology to tissue kallikreins
A˚ke Lundwall1,*, Vimla Band2, Michael Blaber3,
Judith A. Clements4, Yves Courty5, Eleftherios
P. Diamandis6, Hans Fritz7, Hans Lilja8, Johan
Malm1, Lois J. Maltais9, A. Yvonne Olsson10,
Constantina Petraki11, Andreas Scorilas12,
Georgia Sotiropoulou13, Ulf-Ha˚kan Stenman14,
Carsten Stephan15, Maroulio Talieri16 and
George M. Yousef17
Published with the consent of: Mireille Ainciburu5, Maria
Brattsand18, Charlotte Becker1, Adam Clauss1, Mekdes
Debela19, Ying Dong4, Nathalie Heuze´-Vourc’h5, John
Hooper4, Mary-Anne Kedda4, Tadaaki Kishi20, Maciej
Kwiatkowski21, Georgios Pampalakis13, Chris Planque5,
Dan Sexton22, Thomas Takayama23, Olivia Tan4, Antonia
Vlahou24, Astrid Whitbread4
* Corresponding author
e-mail: ake.lundwall@med.lu.se
Abstract
The human kallikrein locus on chromosome 19q13.3–
13.4 contains kallikrein 1 – the tissue kallikrein – and 14
related serine proteases. Recent investigations into their
function and evolution have indicated that the present
nomenclature for these proteins is inadequate or insuffi-
cient. Here we present a new nomenclature in which pro-
teins without proven kininogenase activity are denoted
kallikrein-related peptidase. Names are also given to the
unique rodent proteins that are closely related to kallik-
rein 1.
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Introduction
The term kallikrein (derived from Greek, kallikreas, for
pancreas) was coined by Kraut and colleagues in 1930,
when they demonstrated that an earlier described hypo-
tensive substance in urine is present at high concentra-
tion in the pancreas (Frey and Kraut, 1926; Kraut et al.,
1930). Today, the substance is known as kallikrein 1 or
tissue kallikrein (EC 3.4.21.35), an enzyme that generates
Lys-bradykinin by specific proteolysis of kininogen 1.
There is also a proteolytic enzyme in blood plasma that
gives rise to bradykinin that is known as plasma kallikrein
(EC 3.4.21.34). Several other proteases also exhibit kal-
likrein activity, albeit usually less efficiently than the tissue
and plasma kallikreins. A recent review of the kallikrein-
kinin system is provided by Moreau et al. (2005).
Some 25 years ago, it was shown that mouse and rat
salivary glands secrete proteins with homology to tissue
kallikrein – at that time known as glandular kallikrein
(Bothwell et al., 1979). Owing to their close relationship,
glandular kallikrein and its homologs were assigned to a
subfamily of serine proteinases, which was named the
glandular kallikrein family. Although some of the novel
glandular kallikreins displayed potent kallikrein – i.e., kini-
nogenase – activity, they were primarily considered to be
involved in prohormone processing, as some of them
formed complexes and cleaved precursor proteins of epi-
dermal and nerve growth factors (Thomas et al., 1981;
Blaber et al., 1987). A comprehensive analysis showed
that there were 24 or 25 glandular kallikrein genes in the
mouse genome, designated mGK-1 to mGK-25 (Evans
et al., 1987). Similar analysis of the rat genome identified
10 or 11 glandular kallikrein genes, denoted rGK-1 to
rGK-10 (Wines et al., 1989). In a revision of the kallikrein
nomenclature, the gene family was renamed the tissue
kallikrein gene family and the symbol GK was replaced
by KLK, e.g., the new designation of rGK-4 was rKLK4
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Figure 2 Illustration of the genomic region between Klk1 and Klk4, encompassing taxon-specific genes in the mouse and the rat.
Expressed genes are indicated by filled and pseudogenes by empty arrowheads.
Figure 1 Schematic drawing of the human kallikrein locus on chromosome 19q, 56.0–56.3 Mb.
Approximate locations of genes are indicated by their symbols and arrowheads to mark the direction of transcription. The dashed
lines surrounding KLK3 depict the approximate location of the duplicated region that so far has only been detected in primate species.
The arrows show the location of expanded regions in murine species that contain closely related Klk1 paralogs.
(Berg et al., 1992). In contrast to the large number of
murine genes, the human tissue kallikrein family seemed
to consist of only three genes, which coded for tissue
kallikrein, prostate-specific antigen (PSA) and human
glandular kallikrein 1 (hGK-1) – later renamed human kal-
likrein 2 (hK2) (Fukushima et al., 1985; Lundwall and Lilja,
1987; Schedlich et al., 1987).
The discrepancy in the number of genes was recently
explained by comparative studies on the kallikrein locus
in mammals (Olsson and Lundwall, 2002; Olsson et al.,
2004a,b). These investigations showed that several du-
plications of the tissue kallikrein gene (KLK1) occurred
very late in phylogeny and created 23 KLK1 paralogs that
seem to be unique to the mouse and nine KLK1 paralogs
that seem to be unique to the rat. Late duplication of
KLK1 was also observed in the horse, but not in artio-
dactyls, carnivores, cavian rodents and primates. An-
other, presumably primate-specific, duplication yielded
the hK2 (KLK2) and PSA (KLK3) genes. A functional gene
related to the progenitor of this duplication is present in
the dog, whereas in the mouse and rat there is a non-
functional pseudogene.
Around the turn of the millennium, investigators iden-
tified several genes of simple serine proteases adjacent
to the human tissue kallikrein locus on chromosome
19q13.3–13.4 (Gan et al., 2000; Harvey et al., 2000; You-
sef et al., 2000). The mutual sequence agreement of the
tissue kallikrein family members was higher than the sim-
ilarity between any of the novel serine protease genes.
However, the chromosomal location in combination with
overlapping expression in hormone-dependent tissues
suggested both a common ancestry and overlapping
functionality. Therefore, the old tissue kallikrein family
was expanded with the adjacently located serine protein-
ases into what has become known as the extended kal-
likrein family (Yousef and Diamandis, 2001; Borgonˇo and
Diamandis, 2004; Borgonˇo et al., 2004).
Soon after its discovery, a rational nomenclature was
adopted for members of the extended kallikrein family
(Diamandis et al., 2000). The human kallikrein family, as
we now know it, consists of 15 genes, designated kall-
ikrein 1–15 and denote by the gene symbols KLK1–
KLK15. The nomenclature has served its purpose and is
widely accepted by scientists from many different disci-
plines. However, some shortcomings of the nomencla-
ture have been recognized, as follows:
• The nomenclature was developed for human genes
and does not provide names for unique animal genes;
• The term kallikrein was introduced and has been used
for decades to identify enzymes with kininogenase
activity. Most of the enzymes in the extended kallikrein
family are presumed to not display kininogenase
activity and thus use of the term kallikrein might be
misleading and confusing;
• At present, the nomenclature does not fully comply
with the guidelines provided by the human (http://
www.gene.ucl.ac.uk/nomenclature/guidelines.html)
and mouse (http://www.informatics.jax.org/mgihome/
nomen/gene.shtml) gene nomenclature committees
(HGNC and MGNC), e.g., there should not be two
separate symbols, such as hK1 and KLK1, to depict
the protein and the gene.
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Table 1 Proposed new nomenclature for mouse kallikrein 1-related peptidases – family b.
New gene Old symbol New gene name Alternative and old GenBank
symbol gene names accession no.
Klk1 mGK-6 Kallikrein 1 Tissue kallikrein NM_010639
Klk1b1 mGK-1 Kallikrein 1-related peptidase b1 NM_010645
Klk1b2-ps mGK-2 AY152419
Klk1b3 Ngfg, mGK-3 Kallikrein 1-related peptidase b3 g subunit of the 7S NGF NM_008693
complex
Klk1b4 Ngfa, mGK-4 Kallikrein 1-related peptidase b4 a subunit of the 7S NGF NM_010915
complex
Klk1b5 mGK-5 Kallikrein 1-related peptidase b5 NM_008456
Klk1b7-ps mGK-7 AY152420
Klk1b8 mGK-8 Kallikrein 1-related peptidase b8 NM_008457
Klk1b9 mGK-9, Egfbp3 Kallikrein 1-related peptidase b9 EGF-BP type C, true NM_010116
EGF-BP
Klk1b10-ps mGK-10 AY152421
Klk1b11 mGK-11 Kallikrein 1-related peptidase b11 NM_010640
Klk1b12-ps mGK-12 AY152422
Klk1b14-ps mGK-14 AY152423
Klk1b15-ps mGK-15 AY152424
Klk1b16 mGK-16 Kallikrein 1-related peptidase b16 g-renin NM_008454
Klk1b18-ps mGK-18 AY152426
Klk1b19-ps mGK-19 AY152427
AY152428
Klk1b21 mGK-21 Kallikrein 1-related peptidase b21 NM_010642
Klk1b22 mGk-22, Egfbp1 Kallikrein 1-related peptidase b22 b-NGF endopeptidase, NM_010114
EGF-BP type A
Klk1b23-ps mGK-23 AY152429
Klk1b24 mGK-24 Kallikrein 1-related peptidase b24 NM_010643
Klk1b26 mGK-26, Kallikrein 1-related peptidase b26 Prorenin-converting NM_010644
mGK-13, Egfbp2 enzyme, EGF-BP type B
Klk1b27 mGK-27 Kallikrein 1-related peptidase b27 NM_020268
Klk1b28-ps mGK-28 AY152425
Klk2-ps mGK-25 AY152430
Proposed new nomenclature
The organization of the human kallikrein locus is sche-
matically illustrated, with major discrepancies in mouse,
rat and dog indicated (Figure 1). The human genes are
depicted by the symbols that were introduced in a pre-
vious nomenclature paper (Diamandis et al., 2000). The
same symbols are used in the new nomenclature, despite
the fact that they do not acknowledge the close relation-
ship for KLK1–KLK3. However, the gene names are
changed for all but KLK1, which is still called kallikrein 1.
The new names of KLK2–KLK15 are kallikrein-related
peptidase, followed by the number of the gene symbol,
e.g., KLK2 is kallikrein-related peptidase 2. The symbols
such as hK1, hK2, etc. previously used to depict the pro-
tein should be avoided. To distinguish between the pro-
tein and the gene, the former is written in standard font
(e.g., KLK2) and the latter in italics (e.g., KLK2), as rec-
ommended by HGNC. To distinguish a transcript of a
gene, the relevant abbreviation is written as a prefix with-
in parentheses, e.g., (mRNA)KLK2 and (cDNA)KLK2 to
emphasize the message and complementary DNA of the
gene for kallikrein-related peptidase 2. If the species
needs to be specified, the codes established by SWISS-
PROT should be used (http://www.expasy.ch/cgi-bin/
speclist). The codes are written as a prefix within paren-
theses, e.g., (HUMAN)KLK4 and (MOUSE)Klk4 to distin-
guish between human and mouse KLK4; note that the
gene symbols are written in capital letters, with the
exception of the mouse and rat symbols, which are writ-
ten with an initial capital letter followed by lower case
letters. No species-specific prefix is therefore needed in
articles only relating to the human and mouse genes.
The proposed new nomenclature for unique kallikrein
1-related peptidases in rodents is according to the pro-
posal by Olsson et al. (2004a). They should be named
kallikrein 1-related peptidase followed by a letter depict-
ing the subfamily and the number from the old GK
nomenclature, e.g., the gene cloned with the designation
mGK-5 has the new gene symbol Klk1b5 and is called
kallikrein 1-related peptidase b5. The proposed new
nomenclature for murine kallikrein 1-related peptidases is
displayed in Tables 1 and 2, with their location on the
chromosome illustrated in Figure 2. The gene subfamilies
seem to overlap with single or very closely related animal
species, so that the b-family might be confined to Mus
musculus and the c-family to Rattus norwegicus and
perhaps also Rattus rattus. In non-rodent species, KLK1
expansion is only known to occur in the horse, where the
subfamily is designated by the letter d.
The canine gene with homology to the progenitor of
KLK2 and KLK3 gives rise to the dog prostate arginine
esterase. The proteolytic specificity of this enzyme is
similar to that of KLK2, but not to that of PSA, which
displays an expanded chymotrypsin-like activity (Chap-
delaine et al., 1984; Lazure et al., 1984; Malm et al.,
2000). Thus, it is proper to assign the symbol KLK2 to
the gene for dog arginine esterase and, as a conse-
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Table 2 Proposed new nomenclature of rat kallikrein 1-related peptidases – family c.
New gene Old symbols New gene name Alternative and old Associated Accession no.
symbol gene names pseudogenes
Klk1 rGK-1, PS Kallikrein 1 Tissue kallikrein M11563
Klk1c2 rGK-2, RSKG-5, Kallikrein 1-related Tonin M11565
S2, rKLK2 peptidase c2 Klk15c2-ps BK001365a
Klk2c2-ps
Klk1c3 rGK-3, RSKG-50, Kallikrein 1-related M11564
S1, rKLK3 peptidase c3 Klk15c3-ps BK001366a
Klk2c3-ps BK001376a
Klk1c4 rGK-4, rKLK4 Kallikrein 1-related L33839
peptidase c4 Klk15c4-ps BK001367a
Klk2c4-ps BK001377a
Klk1c6 rGK-6, rKLK6 Kallikrein 1-related BK001361a
peptidase c6 Klk15c6-p BK001368a
Klk2c6-ps BK001378a
Klk1c7 RSKG-7, K1, Kallikrein 1-related Esterase B M19647
rK7, rKLK7 peptidase c7 Klk15c7-ps BK001369a
Klk2c7-ps BK001379a
Klk1c8 rGK-8, P1, Kallikrein 1-related M27215
rK8, rKLK8 peptidase c8 Klk15c8-ps BK001370a
Klk2c8-ps BK001375a
Klk1c9 S3, rK9, SEV, Kallikrein 1-related M11566
rKLK9 peptidase c9 Klk15c9-ps BK001371a
Klk2c9-ps BK001380a
Klk1c10 rK10, rKLK10 Kallikrein 1-related Endopeptidase k, S48142
peptidase c10 T-kininogenase, proteinase B, Klk15c10-ps BK001372a
antigen D3b region Klk2c10-ps BK001381a
Klk1c12 RSKG-3, Kallikrein 1-related M19648
rKLK12 peptidase c12 Klk15c12-ps BK001373a
Klk2c12-ps BK001382a
Klk2-ps BK001374a
Each functional Klk1 paralog on the chromosome is followed by associated pseudogenes that are paralogous with Klk15 and
Klk2, as illustrated in Figure 2.
aThird party annotation that has been removed from GenBank, but is still retrievable.
quence, also to the homologous gene in other species,
such as the rodent pseudogenes that show equally
strong similarity to KLK2 and KLK3.
The nomenclature suggested here is based on our cur-
rent understanding of genes at the kallikrein locus and
may need to be updated in the future as our knowledge
widens. If novel genes are discovered, they should have
the same stem symbol, but with a novel number (e.g.,
KLK16). Genes created by duplication after the diver-
gence of murine rodents from the lineage leading to pri-
mates are exemptions to the rule and should have a
name based on the founder gene.
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